Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid

Retina

Volumn 26, Issue 2, 2006, Pages 210-213

  Dong, Xiaoguang ^a   Chen, Nan ^a   Xie, Lixin ^a   Wang, Shenguo ^b  

^a SHANDONG EYE INSTITUTE   (China)

^b INSTITUTE OF CHEMISTRY   (China)

Author keywords

All trans retinoic acid; Drug delivery system; Proliferative vitreoretinopathy

Indexed keywords

RETINOIC ACID; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; DRUG TISSUE LEVEL; EYE TOXICITY; FIBROBLAST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; NONHUMAN; PROPHYLAXIS; RABBIT; RETINA; VITRECTOMY; VITREORETINOPATHY; ANIMAL; BIODEGRADABLE IMPLANT; DISEASE MODEL; DRUG IMPLANT; METABOLISM; PHYSIOLOGY; VITREOUS BODY;

ABSORBABLE IMPLANTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FIBROBLASTS; LACTIC ACID; POLYGLYCOLIC ACID; POLYMERS; RABBITS; TRETINOIN; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 33645750007     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200602000-00015     Document Type: Article

References (15)

1. The Silicone Study Group. Proliferative vitreoretinopathy [editorial]. Am J Ophthalmol 1985;99:593-595.
2. Blumenkranz M, Hernandez E, Ophir A, Norton EWD. 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 1984;91:122-130.
3. Tano Y, Sugita G, Abrams G, Machemer R. Inhibition of intraocular proliferation with intravitreal corticosteroids. Am J Ophthalmol 1983;96:131-136.
4. Chander DB, Rozakis G, de Juan E, Machemer R. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 1985;99:686-690.
5. Wiedemann P, Lemmen K, Schmiedl R, Heimann K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol 1987;104:10-14.
6. Doyle JW, Dowgiert RK, Buzney SM. Factors modulating the effect of retinoids on cultured retinal pigment epithelial cell proliferation. Curr Eye Res 1992;11:753-765.
7. Campochiaro PA, Hackett SF, Convay BP. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1991;32:65-72.
8. Araiz JJ, Refojo MF, Arroyo MH, et al. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1993;34:522-530.
9. Hooymans JM, De Lavalette VW, Oey AG. Formation of proliferative vitreoretinopathy in primary rhegmatogenous retinal detachment. Doc Ophthalmol 2000;100:39-42.
10. Kawahara J, Buzney SM, Doyle JW. Retinoid levels in the retinal pigment epithelium following experimental retinal detachment in the rabbit. ARVO abstracts. Invest Ophthalmol Vis Sci 1990;31:581.
11. Kim RY, Stern WH. Retinoids and butyrate modulate fibroblast growth and contraction of collagen matrices. Invest Ophthalmol Vis Sci 1990;31:1183-1186.
12. Giordano GG, Refojo MF, Arroyo MH, et al. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest Ophthalmol Vis Sci 1993;34:2743-2751.
13. Nakagawa M, Refojo MF, Marin JF, et al. Retinoic acid in silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1995;36:2388-2395.
14. Fisher SK, Erickson PA, Lewis GP, Anderson DH. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci 1991;32:1739-1747.
15. Moritera T, Ogura Y, Honda Y, et al. Microspheres of biodegradable polymer as a drug delivery system in the vitreous. Invest Ophthalmol Vis Sci 1991;32:1785-1790.